1. Health

Rituxan - Rituximab - Dosage - Side Effects - Interactions - Warnings

Rituxan (Rituximab, MabThera) drug information, dosage, side effects, drug interactions, and warnings. Rituxan, generic drug name rituximab, also known as Mabthera, was first a cancer agent. Rituxan has been approved to be used along with the drug methotrexate to treat rheumatoid arthritis. Rituxan is being studied for conditions such as lupus, lupus nephritis, and vasculitis.
  1. A - Z: Arthritis Drugs
  2. A - Z: Biologics / Blockers
  3. A - Z: Drug Costs
  4. B-Cell Depletion Therapy
  5. Lupus
  6. Methotrexate (Rheumatrex)
  7. Rheumatoid Arthritis
  8. The Fear of Needles
  9. Vasculitis

Rituxan - What You Need to Know
Rituxan has been approved as a treatment option for rheumatoid arthritis.

Rituxan Patients Warned About Progressive Multifocal Leukoencephalopathy
A rheumatoid arthritis patient who participated in an extension of a clinical trial for Rituxan developed progressive multifocal leukoencephalopathy and died.

Subsequent Rituxan Treatment Yields Better Outcomes
11/16/2006, Subsequent Rituxan (rituximab) treatment in patients with rheumatoid arthritis who had an inadequate response to previous treatment with one or more anti-TNF drugs (Enbrel, Remicade, or Humira) produced a better outcome in a higher number of patients than with their first course of Rituxan treatment.

What Is a Monoclonal Antibody?
Some of the biologic drugs used for rheumatoid arthritis are monoclonal antibodies and more are in development.

Are Some Arthritis Patients Unsuitable Candidates For Biologic Drugs?
Rituxan is one of the biologic drug options for inflammatory types of arthritis.

10/31/2005 Rituxan History: Rituxan Granted Priority Review By FDA
10/31/2005, Rituxan (rituximab) has been granted "priority" review status by the U.S. Food and Drug Administration as a treatment for rheumatoid arthritis.

04/07/2005 Rituxan History: Phase III Study For Rituxan Meets Endpoint
04/07/2005, The Phase III study of Rituxan for the treatment of rheumatoid arthritis has demonstrated that more study participants treated with Rituxan achieved ACR20 (20% improvement in symptoms) at week 24 compared to placebo.

06/17/2004 Rituxan History: Rituxan Promising For Rheumatoid Arthritis
06/17/2004, Rituxan, a drug used to target B-cells, is showing promise as a treatment for rheumatoid arthritis.

10/26/2003 Rituxan History: Rituxan Shows Benefit In Phase II Trials
10/26/2003, A single, short course of treatment with Rituxan (two infusions during the first 15 days of treatment) alone, or in combination with methotrexate or cyclophosphamide improved symptoms in patients with moderate to severe rheumatoid arthritis for up to 48 weeks, compared to methotrexate alone.

06/01/2001 Rituxan History: B-Cell: Is Progress Being Made?
06/01/2001, News of exciting research developments and a potential cure for rheumatoid arthritis was splashed everywhere last November.

B-Cell Depletion Triggers Rheumatoid Arthritis Remission
Researchers from University College in London have presented findings from an experimental new rheumatoid arthritis treatment - B-lymphocyte depletion.

11/20/2000 Rituxan History: B-Cell Depletion Wading Through The Hype
11/20/2000, Were the recent reports which hyped B-lymphocyte depletion therapy as a potential cure for rheumatoid arthritis accurate or were the reports irresponsible journalism?

A - Z: Drug Side Effects
A - Z: Drug Side Effects

You can opt-out at any time. Please refer to our privacy policy for contact information.

Discuss in my forum

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.